metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Most often read
Journal Information

Most often read

131499
COVID-19 and the liver: What do we know after six months of the pandemic?
Nora A. Fierro
Ann Hepatol. 2020;19:590-1
131499
Open access
Open Article
26506
Ocular manifestations of liver disease in children: Clinical aspects and implications
Durga Prasad, Arpita Bhriguvanshi
Ann Hepatol. 2020;19:608-13
26506
Open access
22543
The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease
Daniel Iluz-Freundlich, Manna Zhang, Julia Uhanova, Gerald Y. Minuk
Ann Hepatol. 2020;19:204-8
22543
Open access
14049
The liver in times of COVID-19: What hepatologists should know
Ezequiel Ridruejo, Alejandro Soza
Ann Hepatol. 2020;19:353-8
14049
Open access
Open Article
13583
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos
Ann Hepatol. 2020;19:134-44
13583
Open access
13441
Bacterial infections in cirrhosis: Current treatment
Godolfino Miranda-Zazueta, Luis A. Ponce de León-Garduño, Jonathan Aguirre-Valadez, Aldo Torre-Delgadillo
Ann Hepatol. 2020;19:238-44
13441
Open access
10057
Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case
Raquel D. Greca, Marlone Cunha-Silva, Larissa B.E. Costa, Júlia G.F. Costa, Daniel F.C. Mazo, Tiago Sevá-Pereira, Marlla M.C. Nascimento, Isadora E. Pereira, ... Jazon R.S. Almeida
Ann Hepatol. 2020;19:107-12
10057
Open access
10027
A systematic review and meta-analysis of the COVID-19 associated liver injury
Yu Jun Wong, Malcolm Tan, Qishi Zheng, James Weiquan Li, Rahul Kumar, Kwong Ming Fock, Eng Kiong Teo, Tiing Leong Ang
Ann Hepatol. 2020;19:627-34
10027
Open access
Open Article
8496
The effect of liver test abnormalities on the prognosis of COVID-19
Alpay Medetalibeyoglu, Yunus Catma, Naci Senkal, Asli Ormeci, Bilger Cavus, Murat Kose, Osman Faruk Bayramlar, Gulcan Yildiz, ... Tufan Tukek
Ann Hepatol. 2020;19:614-21
8496
Open access
Open Article
7619
Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations
María-Jimena Muciño-Bermejo
Ann Hepatol. 2020;19:145-52
7619
Open access
6147
ABCB4 disease: Many faces of one gene deficiency
Eva Sticova, Milan Jirsa
Ann Hepatol. 2020;19:126-33
6147
Open access
5261
Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?
Diego García-Compeán, Jesús Zacarías Villarreal-Pérez, Manuel Enrique de la O. Cavazos, Fernando Javier Lavalle-Gonzalez, Omar David Borjas-Almaguer, Angel Noé Del Cueto-Aguilera, José Alberto González-González, Consuelo Treviño-Garza, ... Héctor Jesús Maldonado-Garza
Ann Hepatol. 2020;19:258-64
5261
Open access
5174
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies
Alessio Gerussi, Daphne D’Amato, Laura Cristoferi, Sarah Elizabeth O’Donnell, Marco Carbone, Pietro Invernizzi
Ann Hepatol. 2020;19:5-16
5174
Open access
5168
Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis
Angelo A. Mattos, Denusa Wiltgen, Raquel F. Jotz, Caroline M.R. Dornelles, Matheus V. Fernandes, Ângelo Z. Mattos
Ann Hepatol. 2020;19:451-7
5168
Open access
5142
Osteopontin – A potential biomarker of advanced liver disease
Radan Bruha, Libor Vitek, Vaclav Smid
Ann Hepatol. 2020;19:344-52
5142
Open access
5132
SARS-CoV-2 another kind of liver aggressor, how does it do that?
Sonia A. Lozano-Sepulveda, Kame Galan-Huerta, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Ana María Rivas-Estilla
Ann Hepatol. 2020;19:592-6
5132
Open access
Open Article
5082
Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher
Ann Hepatol. 2020;19:359-66
5082
Open access
4973
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
Rommel Zambrano-Huailla, Laura Guedes, Jose Tadeu Stefano, Arthur A. Arrais de Souza, Sebastián Marciano, Erika Yvamoto, Matheus Truccolo Michalczuk, Denise Siqueira Vanni, ... Claudia P. Oliveira
Ann Hepatol. 2020;19:622-6
4973
Open access
4856
Effects of hepatitis B virus infection, alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase on prediabetes and diabetes mellitus: A cohort study
Ting Gan, Ning Cheng, Jiao Ding, Zhiyuan Cheng, Desheng Zhang, Haiyan Li, Juansheng Li, Na Li, ... Yana Bai
Ann Hepatol. 2020;19:197-203
4856
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos